Sterghios A. Moschos

115 New Cavendish Str, W1W 6UW
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinically confirmed cohort reveals antioxidant genetic polymorphisms as potential susceptibility factors for long COVID after mild or asymptomatic COVID-19.

Clinically confirmed cohort reveals antioxidant genetic polymorphisms as potential susceptibility factors for long COVID after mild or asymptomatic COVID-19.

Journal: Free radical biology & medicine

Published: October 31, 2025

The Idiopathic Pulmonary Fibrosis-Associated Single Nucleotide Polymorphism RS35705950 Is Transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979.1).

The Idiopathic Pulmonary Fibrosis-Associated Single Nucleotide Polymorphism RS35705950 Is Transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979.1).

Journal: Non-coding RNA

Published: October 01, 2022

Bacterial Adaptation to Venom in Snakes and Arachnida.

Bacterial Adaptation to Venom in Snakes and Arachnida.

Journal: Microbiology spectrum

Published: May 23, 2022

Beyond GalNAc! Drug delivery systems comprising complex oligosaccharides for targeted use of nucleic acid therapeutics.

Beyond GalNAc! Drug delivery systems comprising complex oligosaccharides for targeted use of nucleic acid therapeutics.

Journal: RSC advances

Published: March 28, 2022

The emerging field of venom-microbiomics for exploring venom as a microenvironment, and the corresponding Initiative for Venom Associated Microbes and Parasites (iVAMP).

The emerging field of venom-microbiomics for exploring venom as a microenvironment, and the corresponding Initiative for Venom Associated Microbes and Parasites (iVAMP).

Journal: Toxicon: X

Published: June 19, 2020

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).

Journal: International journal of molecular medicine

Published: April 20, 2020

A new threat from an old enemy: Re‑emergence of coronavirus (Review).

A new threat from an old enemy: Re‑emergence of coronavirus (Review).

Journal: International journal of molecular medicine

Published: March 23, 2020

Predicting oligonucleotide therapeutic efficacy at the population level.

Predicting oligonucleotide therapeutic efficacy at the population level.

Journal: Hellenic journal of nuclear medicine

Published: October 21, 2019

Measuring the Action of Oligonucleotide Therapeutics in the Lung at the Cell Type-Specific Level by Tissue Disruption and Cell Sorting (TDCS).

Measuring the Action of Oligonucleotide Therapeutics in the Lung at the Cell Type-Specific Level by Tissue Disruption and Cell Sorting (TDCS).

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 15, 2019

RACE-SEQ and Population-Wide Polymorphism Susceptibility Testing for Endonucleolytically Active, RNA-Targeting Therapeutics.

RACE-SEQ and Population-Wide Polymorphism Susceptibility Testing for Endonucleolytically Active, RNA-Targeting Therapeutics.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 15, 2019

Extracellular vesicles and their nucleic acids for biomarker discovery.

Extracellular vesicles and their nucleic acids for biomarker discovery.

Journal: Pharmacology & therapeutics

Published: August 07, 2018

A novel antifungal property for the Bacillus licheniformis ComX pheromone and its possible role in inter-kingdom cross-talk.

A novel antifungal property for the Bacillus licheniformis ComX pheromone and its possible role in inter-kingdom cross-talk.

Journal: Applied microbiology and biotechnology

Published: February 15, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026